Medical devices, healthcare technology and the business of care
510(k) clearance · K253470

MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894)

Medtronic MiniMed, Inc. · Decision date Jan 15, 2026

FDA DECISIONK253470

What did the FDA decide?

FDA records K253470 as a 510(k) premarket notification, with a decision dated Jan 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Clinical Chemistry
Decision date
Jan 15, 2026

FDA source record

Regulatory record facts

Identifier
K253470
Regulatory pathway
510(k) premarket notification
Product code
QFG
Decision code
SESE
Decision date
Jan 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Alternate Controller Enabled Insulin Infusion Pump.

Product code
QFG
FDA device class
2

FDA decision timeline

  1. K253470 received

    Application receipt date recorded by FDA.

  2. K253470 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QFG

Product / regulatory recordCompanyPathwayDecision dateSource
Beta Bionics, Inc.510(k) clearanceOct 21, 2026FDA
Beta Bionics, Inc.510(k) clearanceSep 11, 2026FDA
Deka Research and Development510(k) clearanceJun 17, 2026FDA
Beta Bionics, Inc.510(k) clearanceApr 30, 2026FDA
Medtronic MiniMed, Inc.510(k) clearanceMar 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
Northridge, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records